A detailed history of Amalgamated Bank transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Amalgamated Bank holds 27,029 shares of CORT stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,029
Previous 27,635 2.19%
Holding current value
$1.45 Million
Previous $898,000 39.31%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$29.51 - $46.26 $17,883 - $28,033
-606 Reduced 2.19%
27,029 $1.25 Million
Q2 2024

Aug 12, 2024

SELL
$22.21 - $34.48 $13,925 - $21,618
-627 Reduced 2.22%
27,635 $898,000
Q1 2024

Apr 23, 2024

SELL
$21.1 - $27.46 $187,283 - $243,734
-8,876 Reduced 23.9%
28,262 $712,000
Q4 2023

Feb 06, 2024

SELL
$24.82 - $32.88 $34,226 - $45,341
-1,379 Reduced 3.58%
37,138 $1.21 Million
Q3 2023

Nov 08, 2023

SELL
$21.97 - $33.8 $31,614 - $48,638
-1,439 Reduced 3.6%
38,517 $1.05 Million
Q2 2023

Aug 11, 2023

SELL
$21.44 - $25.15 $52,270 - $61,315
-2,438 Reduced 5.75%
39,956 $889,000
Q1 2023

May 02, 2023

SELL
$19.2 - $24.47 $51,724 - $65,922
-2,694 Reduced 5.97%
42,394 $918,000
Q4 2022

Feb 10, 2023

SELL
$19.95 - $29.96 $1,635 - $2,456
-82 Reduced 0.18%
45,088 $916,000
Q3 2022

Nov 09, 2022

BUY
$24.7 - $29.12 $20,525 - $24,198
831 Added 1.87%
45,170 $1.16 Million
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $20,674 - $30,182
-1,193 Reduced 2.62%
44,339 $1.05 Million
Q1 2022

Jun 30, 2022

SELL
$16.53 - $25.21 $64,516 - $98,394
-3,903 Reduced 7.9%
45,532 $1.03 Million
Q4 2021

Feb 15, 2022

SELL
$17.1 - $23.34 $76,437 - $104,329
-4,470 Reduced 8.29%
49,435 $979,000
Q3 2021

Oct 29, 2021

SELL
$19.68 - $22.53 $19,502 - $22,327
-991 Reduced 1.81%
53,905 $1.06 Million
Q2 2021

Aug 16, 2021

BUY
$19.97 - $24.43 $801,495 - $980,498
40,135 Added 271.9%
54,896 $1.21 Million
Q1 2021

May 13, 2021

SELL
$23.49 - $30.56 $31,547 - $41,042
-1,343 Reduced 8.34%
14,761 $351,000
Q4 2020

Feb 12, 2021

BUY
$16.78 - $27.3 $5,889 - $9,582
351 Added 2.23%
16,104 $421,000
Q3 2020

Oct 30, 2020

SELL
$12.46 - $19.98 $6,441 - $10,329
-517 Reduced 3.18%
15,753 $274,000
Q2 2020

Aug 10, 2020

SELL
$11.0 - $18.26 $19,316 - $32,064
-1,756 Reduced 9.74%
16,270 $274,000
Q1 2020

May 13, 2020

SELL
$10.11 - $14.04 $7,986 - $11,091
-790 Reduced 4.2%
18,026 $214,000
Q4 2019

Feb 13, 2020

BUY
$12.06 - $16.96 $7,043 - $9,904
584 Added 3.2%
18,816 $228,000
Q3 2019

Nov 13, 2019

SELL
$10.41 - $14.66 $1,925 - $2,712
-185 Reduced 1.0%
18,232 $258,000
Q2 2019

Aug 14, 2019

BUY
$9.78 - $12.76 $21,975 - $28,671
2,247 Added 13.9%
18,417 $205,000
Q1 2019

May 15, 2019

BUY
$10.03 - $15.71 $2,768 - $4,335
276 Added 1.74%
16,170 $190,000
Q4 2018

Feb 15, 2019

BUY
$11.29 - $17.19 $179,443 - $273,217
15,894 New
15,894 $212,000
Q3 2018

Nov 14, 2018

SELL
$12.27 - $15.65 $194,393 - $247,942
-15,843 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$15.3 - $19.69 $40,743 - $52,434
2,663 Added 20.2%
15,843 $249,000
Q1 2018

May 22, 2018

SELL
$14.59 - $25.5 $3,093 - $5,406
-212 Reduced 1.58%
13,180 $217,000
Q4 2017

Feb 13, 2018

BUY
$15.77 - $20.72 $28,591 - $37,565
1,813 Added 15.66%
13,392 $242,000
Q3 2017

Nov 09, 2017

BUY
$12.3 - $19.3 $142,421 - $223,474
11,579
11,579 $223,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.76B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.